Cervical Cancer

Clinical Trials

Below is a list of Cervical Cancer clinical trials from the clinical trials database at Mayo Clinic.

This list includes only trials about which Mayo researchers choose to publish information. Mayo Clinic may be conducting other trials which are not in this database. Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.

GOG-0219, A Phase III, Randomized Study of Weekly Cisplatin and Radiation versus Cisplatin and Tirapazamine (IND #46525) and Radiation in Stage IB2, IIA, IIB, IIIB and IVA Cervical Cancer Limited to the Pelvis
Patients are being asked to take part in this research study because they have cancer of the cervix. This study is being done to determine if combining Tirapazamine (TPZ) with Cisplatin during radiation therapy increases the amount of time until a patient's cancer returns compared with Cisplatin and radiation therapy alone.

The Tirapazamine (TPZ) used in this study is considered investigational, which means it has not been approved by the U.S. Food and Drug Administration (FDA) for either routine clinical use or for the use described in this study. However, the FDA has allowed the use of this drug in this research study.
Read more